Synthesis and in-vitro antibacterial activities of acetylanthracene and acetylphenanthrene derivatives of some fluoroquinolones

Iranian Journal of Pharmaceutical Research

Volumn 10, Issue 2, 2011, Pages 225-231

  Shamsa, Fazel ^a   Foroumadi, Alireza ^b   Shamsa, Hashim ^a   Samadi, Nasrin ^c   Faramarzi, Mohammad Ali ^c   Shafiee, Abbas ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anthracene derivatives; In vitro antibacterial activity; N substituted piperazinyl quinolones; Phenanthrene derivatives

Indexed keywords

1 CYCLOPROPYL 6 FLUORO 1, 4 DIHYDRO 7 [4 [2 (ANTHRACEN 2 YL) 2 OXOETHYL]PIPERAZIN 1 YL] 4 OXO 3 QUINOLINE CARBOXYLIC ACID; 1 CYCLOPROPYL 6 FLUORO 1, 4 DIHYDRO 7 [4 [2 (ANTHRACEN 9 YL) 2 OXOETHYL]PIPERAZIN 1 YL] 4 OXO 3 QUINOLINE CARBOXYLIC ACID; 1 CYCLOPROPYL 6 FLUORO 1, 4 DIHYDRO 7 [4 [2 (PHENANTHREN 2 YL) 2 OXOETHYL]PIPERAZIN 1 YL] 4 OXO 3 QUINOLINE CARBOXYLIC ACID; 1 CYCLOPROPYL 6 FLUORO 7 [4 [2 (ANTHRACEN 2 YL) 2 OXOETHYL]PIPERAZIN 1 YL] 8 METHOXY 4 OXO 3 QUINOLINE CARBOXYLIC ACID; 1 CYCLOPROPYL 6 FLUORO 7 [4 [2 (ANTHRACEN 9 YL) 2 OXOETHYL]PIPERAZIN 1 YL] 8 METHOXY 4 OXO 3 QUINOLINE CARBOXYLIC ACID; 1 CYCLOPROPYL 6 FLUORO 7 [4 [2 (PHENANTHREN 2 YL) 2 OXOETHYL]PIPERAZIN 1 YL] 8 METHOXY 4 OXO 3 QUINOLINE CARBOXYLIC ACID; 1 EHTYL 6 FLUORO 1, 4 DIHYDRO 7 [4 [2 (ANTHRACEN 2 YL) 2 OXOETHYL]PIPERAZIN 1 YL] 4 OXO 3 QUINOLINE CARBOXYLIC ACID; 1 ETHYL 6 FLUORO 1, 4 DIHYDRO 7 [4 [2 (ANTHRACEN 9 YL) 2 OXOETHYL]PIPERAZIN 1 YL] 4 OXO 3 QUINOLINE CARBOXYLIC ACID; 1 ETHYL 6 FLUORO 1, 4 DIHYDRO 7 [4 [2 (PHENANTHREN 2 YL) 2 OXOETHYL]PIPERAZIN 1 YL] 4 OXO 3 QUINOLINE CARBOXYLIC ACID; 2 OXO 2 (ANTHRACENE 2 YL)ETHYL; 2 OXO 2 (ANTHRACENE 9 YL)ETHYL; 2 OXO 2 (PHENANTHRENE 2 YL)ETHYL; 3 ACETYLPHENANTHRENE; 7 [4 (2 ARYL 2 OXOETHYL) 1 PIPERAZINYL]QUINOLONE DERIVATIVE; ACETYLANTHRACENE; ACETYLPHENANTHRENE DERIVATIVE; ANTHRACENE DERIVATIVE; CIPROFLOXACIN; GATIFLOXACIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SESQUITERPENE DERIVATIVE; TERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; OSMOLARITY;

EID: 79959397465     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. rd ed. Churchill Livingstone Inc. New York (1990) 334-345.
2. Lescher GY, Froelich EJ, Gruett MD, Bailey JH and Brundage RP. 1,8-Naphthyridine derivatives. A new class of chemotherapeutic agents. J. Med. Pharm. Chem. (1962) 91: 1063-1065.
3. Emami S, Shafiee A and Foroumadi A. Quinolones: recent structural and clinical developments. Iranian J. Pharm. Res. (2005) 3: 123-136.
4. Higgins PG, Fluit AC and Schmitz FJ. Fluoroquinolones: structure and target sites. Current Drugs Targets (2003) 4: 181-190.
5. Koga H, Itoh A, Murayama S, Suzue S and Lrikura T. Structure-activity relationship of anti-bacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinolone-3-carboxylic acids. J. Med. Chem. (1980) 23: 13581363.
6. Emami S, Shafiee A and Foroumadi A. Structural feature of new quinolones and relationship to antibacterial activity against Gram-positive bacteria. Mini- Reviews in Medicinal Chemistry (2006) 6: 375386.
7. Domagala JM, Hanna LD, Heifetz CL Hurt MP, Mich TF, Sanchez JP and Solomon M. New structure activity relationship of the quinolone antibacterial using the target enzyme. J. Med. Chem. (1986) 29: 394-404.
8. Shen LL, Mitscher LA, Sharma PN O' Donnell TJ, Chu DWT, Copper CS, Rosen T. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding model. Biochemistry (1989) 28: 3886-3894.
9. Cooper CS, Klock PL, Chu DT, Hardy DJ, Swanson RN and Plattner JJ. Preparation and in-vitro and in-vivo evaluation of quinolones with selective activity against gram-positive organism. J. Med. Chem. (1992) 35: 1392-8.
10. Shafiee A, Haddad Zahmatkesh M, Mohammadhosseini N, Khalafy J, Emami S, Moshafi MH, Sorkhi M and Foroumadi A. Synthesis and in-vitro antibacterial activity of JV-piperazinyl quinolone derivatives with 5-chloro-2-thienyl group. Daru (2008) 16: 189-195.
11. Letafat BS, Emami S, Mohammadhosseini N, Faramarzi MA, Samadi N, Shafiee A and Foroumadi A. Synthesis and antibacterial activity of new N-[2- (thiophen-3-yl)ethyl]piperazinyl quinolones. Chem. Pharm. Bull. (2007) 55: 894-898.
12. Foroumadi A, Mohammadhosseini N, Emami S, Letafat B, Faramarzi MA, Samadi N and Shafiee A. Synthesis and antibacterial activity of new 7-piperazinyl- quinolones containing a functionalized 2-(furan-3-yl) ethyl. Arch. Pharm. Chem. Life Sci. (2007) 340: 47-52.
13. Foroumadi A, Emami S, Mansouri S, Javidnia A, Saeid-Adeli N, Shirazi FH and Shafiee A. Synthesis and antibacterial activity of levofloxacin derivatives with certain bulky residues on piperazine rings. Eur. J. Med. Chem. (2007) 42: 985-992.
14. Emami S, Foroumadi A, Faramarzi MA and Samadi N. Synthesis and antibacterial activity of quinolonebased compounds containing a coumarin moiety. Arch. Pharm. Chem. Life Sci. (2008) 341: 42-48.
15. Shafiee A, Emami S, Ghodsi S, Najjari S, Sorkhi M, Samadi N, Faramarzi MA and Foroumadi A. Synthesis and antibacterial activity of N-[2-(2-naphthyl)ethyl] piperazinyl quinolones. J. Iranian Chem. Soc. (2009) 6: 325-333.
16. th ed., CV Mosby Company, St. Louis (2002) 235-236.
17. Jazayeri S, Moshafi MH, Firoozpour L, Emami S, Rajabalian S, Haddad M, Pahlavanzadeh F, Esnaasharia M, Shafiee A and Foroumadi A. Synthesis and antibacterial activity of nitroaryl thiadiazole-gatifloxacin hybrids. Eur. J. Med. Chem. (2009) 44: 1205-1209.